The primordial radionuclides activity concentrations (226Ra, 40K and 232Th) are measured in some granite samples in this study. The collected granite materials are analyzed with NaI(Tl) gamma-ray spectrometry. The specific activity of 226Ra, 232Th and 40K values are in range 2.60 ± 0.10 to 178.9 ± 0.6 Bq kg−1, 1.46 ± 0.10 to 162.50 ± 0.75 Bq kg−1 and 19.8 ± 0.3 to 579.7 ± 2.8 Bq kg−1 respectively. The radium’s equivalent activity, annual effective dose, absorbed dose rate, hazard index, radioactivity level index, activity utilization’s index and exposure rate are calculated for determination of radiological risk. The concentration of 226Ra (in the 71.4% of samples), 232Th (in the 71.4% of samples) and 40K (in the 14.3% of samples) in the granite samples are higher than average radioactivity concentrations of this radio-isotopes defined by ICRP (35.0, 30.0 and 400.0 Bq kg−1, respectively).
18 December 2022 in Journal of Environmental Radioactivity
This study introduces a novel four-parameter lifetime distribution constructed within the Topp–Leone Power Gompertz framework. Owing to its flexible structure, the proposed model accommodates a wide range of density shapes and hazard-rate patterns, including increasing, decreasing, bathtub-shaped, unimodal, and other non-monotone behaviors. Key distributional properties, including moments, entropy-based measures, quantile-based measures, and order statistics, are derived. Parameter inference is conducted using both likelihood-based and Bayesian approaches, and the finite-sample performance of the resulting estimators is assessed via Monte Carlo simulations. The practical relevance of the proposed distribution is illustrated using two real datasets and benchmarked against several competing lifetime models, including the Gompertz, Power Gompertz, Weibull, Topp–Leone Gompertz, Marshall–Olkin Gompertz, and Exponentiated Gompertz distributions. Overall, the comparative analyses demonstrate the superior fitting performance of the proposed model, highlighting its effectiveness for complex reliability, survival, and pharmacokinetic data.